TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20353624

Group type: EXPERIMENTAL
Intervention: Rivastigmine 1.5 mg once a day, increasing to 1.5 mg twice a day after seven days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (identical tablets)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 18550954

Group type: EXPERIMENTAL
Intervention: Squat group (Sq) - 3 series of 3 squat repetitions at 90% of individual maximum value and a sprint before agility circuit
Number of subjects: 26

Group type: COMPARATOR
Intervention: Reference group (Re) - individual technical work only
Number of subjects: 26

Group type: COMPARATOR
Intervention: Coordination group (Co) - circuit designed to promote agility, coordination, and balance control with some technical work
Number of subjects: 26
Study: 16597218

Group type: EXPERIMENTAL
Intervention: Multisystemic therapy (MST)
Number of subjects: 93
Study: 14643271

Group type: EXPERIMENTAL
Intervention: Chronic periodontitis (CP) in AMI group
Number of subjects: 160

Group type: COMPARATOR
Intervention: Chronic periodontitis (CP) in non-AMI group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Bone loss exceeding 4mm at >/=50% of teeth in AMI group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Bone loss exceeding 4mm at >/=50% of teeth in non-smokers
Number of subjects: 160
Study: 10981486

Group type: EXPERIMENTAL
Intervention: Methylprednisolone followed by prednisolone (group B)
Number of subjects: 26

Group type: COMPARATOR
Intervention: None (group A and group C)
Number of subjects: 26
Study: 9208532

Group type: EXPERIMENTAL
Intervention: Combined therapy of TCM and chemotherapy (Group A)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Chemotherapy alone (Group B)
Number of subjects: 102
Study: 1579962

Group type: EXPERIMENTAL
Intervention: Hemodilution therapy (venesection/dextran 40)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 6717888

Group type: EXPERIMENTAL
Intervention: Lonidamine plus adriamycin
Number of subjects: 25

Group type: COMPARATOR
Intervention: Adriamycin alone
Number of subjects: 25
Study: 29715705

Group type: EXPERIMENTAL
Intervention: Trifecta valve
Number of subjects: 100

Group type: COMPARATOR
Intervention: Perimount Magna Ease valve
Number of subjects: 100
Study: 29196962

Group type: EXPERIMENTAL
Intervention: Moral Injury Symptom Scale-Military Version (MISS-M)
Number of subjects: 427
Study: 27466699

Group type: EXPERIMENTAL
Intervention: Somatostatin analogs (SAs)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 18
Study: 24804185

Group type: EXPERIMENTAL
Intervention: Topical Achilles millefolium 5% gel (twice daily for four weeks) along with weekly intralesional Glucantime injections
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (twice daily for four weeks) along with weekly intralesional Glucantime injections
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Topical Achilles millefolium 5% gel
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 22161686

Group type: EXPERIMENTAL
Intervention: PTH(1-84) 100 µg/day subcutaneously
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 19949852

Group type: EXPERIMENTAL
Intervention: Tactile feedback system using a sensor mat to detect problematic postures.
Number of subjects: 0
Study: 18984456

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS) ON
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS) OFF
Number of subjects: 11

Group type: COMPARATOR
Intervention: CSX patients compared to healthy controls
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: SCS ON vs SCS OFF
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: SCS OFF phase
Number of subjects: 11
Study: 15891150

Group type: EXPERIMENTAL
Intervention: O(2)-O(3) infiltration
Number of subjects: 306

Group type: COMPARATOR
Intervention: Steroid injection
Number of subjects: 306
Study: 12371526

Group type: EXPERIMENTAL
Intervention: BDP 500 microg bid via MDI with HFA-134a
Number of subjects: 116

Group type: COMPARATOR
Intervention: CFC propellant (Becotide)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both groups (BDP HFA and CFC)
Number of subjects: 116
Study: 10618940

Group type: EXPERIMENTAL
Intervention: Clonidine bolus of 25 micrograms and infusion of 19 micrograms h‐1 added to 0.03% bupivacaine
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Clonidine bolus of 50 micrograms and infusion of 37 micrograms h‐1 added to 0.03% bupivacaine
Number of subjects: 45

Group type: COMPARATOR
Intervention: 0.03% bupivacaine alone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Both clonidine groups
Number of subjects: 45
Study: 8554488

Group type: EXPERIMENTAL
Intervention: Dipyridamole echocardiography (DET)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Exercise stress test
Number of subjects: 78

Group type: COMPARATOR
Intervention: Tc99MIBI-dipyridamole planar myocardial scintigraphy
Number of subjects: 78
Study: 1767060

Group type: EXPERIMENTAL
Intervention: 5 mg/mq of i.v. cisplatin administered 30-60 minutes before each radiation therapy session (Group A)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 96
Study: 6754242

Group type: EXPERIMENTAL
Intervention: Monofluorophosphate dentifrice
Number of subjects: 2008

Group type: EXPERIMENTAL
Intervention: Amine fluoride dentifrice
Number of subjects: 2008

Group type: COMPARATOR
Intervention: Control group (toothpaste without fluoride)
Number of subjects: 2008
Study: 29725851

Group type: EXPERIMENTAL
Intervention: LPF+ADM
Number of subjects: 22

Group type: COMPARATOR
Intervention: LPF
Number of subjects: 22
Study: 29787288

Group type: EXPERIMENTAL
Intervention: Zephyr Endobronchial Valve (EBV)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 190
Study: 27380343

Group type: EXPERIMENTAL
Intervention: Palliative care-led meetings with informational brochure
Number of subjects: 365

Group type: COMPARATOR
Intervention: Routine family meetings with informational brochure
Number of subjects: 365
Study: 24965834

Group type: EXPERIMENTAL
Intervention: Human-powered nebuliser with 2.5 mg dose of salbutamol
Number of subjects: 110

Group type: COMPARATOR
Intervention: Electric nebuliser with 2.5 mg dose of salbutamol
Number of subjects: 110
Study: 22240597

Group type: EXPERIMENTAL
Intervention: voglibose (0.9 mg/day)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: nateglinide (180 mg/day)
Number of subjects: 302

Group type: COMPARATOR
Intervention: lifestyle intervention
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Improved glycemic status
Number of subjects: 302
Study: 20061334

Group type: EXPERIMENTAL
Intervention: Lanreotide (30 mg/2 weeks i.m. increasing to 30 mg/week i.m. at week 8 if mean GH >2.5 microg/l)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Transsphenoidal surgery
Number of subjects: 108
Study: 17028419

Group type: EXPERIMENTAL
Intervention: Oral prednisone (25 mg o.d. for 4 days)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 14706319

Group type: EXPERIMENTAL
Intervention: Cotrel‐Dubousset instrumentation system
Number of subjects: 82

Group type: COMPARATOR
Intervention: Colorado instrumentation system
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both instrumentation systems
Number of subjects: 82
Study: 11748092

Group type: EXPERIMENTAL
Intervention: γ-irradiation (192Ir) for native coronary artery ISR
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: γ-irradiation (192Ir) for saphenous vein graft ISR
Number of subjects: 78

Group type: COMPARATOR
Intervention: Comparison of native artery ISR and SVG ISR
Number of subjects: 78
Study: 9554247

Group type: EXPERIMENTAL
Intervention: Cyclofem
Number of subjects: 100

Group type: COMPARATOR
Intervention: DMPA
Number of subjects: 100
Study: 7803596

Group type: EXPERIMENTAL
Intervention: Bright white morning light (tau 2500 lux)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Bright white evening light (tau 2500 lux)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Dim red evening light (< 10 lux)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control (NC)
Number of subjects: 31
Study: 3152402

Group type: EXPERIMENTAL
Intervention: Continuous Wave Doppler (CW)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Pulsed Doppler (PD)
Number of subjects: 14
Study: 31623766

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 1900

Group type: COMPARATOR
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 1900
Study: 28686474

Group type: EXPERIMENTAL
Intervention: Low-dose aripiprazole (5 mg/day if <50 kg; 10 mg/day if ≥50 kg)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: High-dose aripiprazole (10 mg/day if <50 kg; 20 mg/day if ≥50 kg)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 25220550

Group type: EXPERIMENTAL
Intervention: Aprepitant 80 mg + Dexamethasone 8 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dexamethasone 8 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aprepitant + Dexamethasone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dexamethasone
Number of subjects: 60
Study: 23591120

Group type: EXPERIMENTAL
Intervention: Intermittent energy restriction (IECR)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Intermittent energy and carbohydrate restriction with ad libitum protein and fat (IECR+PF)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Daily energy restriction (DER)
Number of subjects: 115
Study: 21281406

Group type: EXPERIMENTAL
Intervention: Mebendazole (500 mg single dose)
Number of subjects: 1042

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1042

Group type: EXPERIMENTAL
Intervention: Mebendazole
Number of subjects: 1042

Group type: EXPERIMENTAL
Intervention: Higher intensities of hookworm and Trichuris infections
Number of subjects: 1042

Group type: EXPERIMENTAL
Intervention: Moderate/heavy Trichuris infection
Number of subjects: 1042

Group type: EXPERIMENTAL
Intervention: Moderate/heavy hookworm co-infection
Number of subjects: 1042
Study: 19930566

Group type: EXPERIMENTAL
Intervention: 7.5% hypertonic saline in 6% dextran 70, single dose of 250 ml
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 0
Study: 15010401

Group type: EXPERIMENTAL
Intervention: Controlled-release codeine (CC)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Acetaminophen plus codeine (A/C; 300 mg/30 mg)
Number of subjects: 84
Study: 10358130

Group type: EXPERIMENTAL
Intervention: High carbohydrate (CHO) diet (80% of energy as CHO)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Low carbohydrate (CHO) diet (10% of energy as CHO)
Number of subjects: 6
Study: 8586009

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nitrendipine
Number of subjects: 21
Study: 1967533

Group type: EXPERIMENTAL
Intervention: 15 mg temazepam
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 30 mg temazepam
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 7426335

Group type: EXPERIMENTAL
Intervention: Early diagnostic splenectomy
Number of subjects: 67

Group type: COMPARATOR
Intervention: Total nodal irradiation (control)
Number of subjects: 67
Study: 30375070

Group type: EXPERIMENTAL
Intervention: Adenosine (Ado) 18-36 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isoproterenol (Iso) 3-20 µg/min
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isoproterenol (Iso)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Adenosine (Ado)
Number of subjects: 40
Study: 28626249

Group type: EXPERIMENTAL
Intervention: Knowledge of free delivery policy
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Education level
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Length of stay
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Receiving transportation support
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Satisfaction with quality of services
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Accessibility to health facilities
Number of subjects: 360
Study: 27128565

Group type: EXPERIMENTAL
Intervention: Low sodium salt substitute (65% NaCl, 25% KCl, 10% MgSO4)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Normal salt (100% sodium chloride)
Number of subjects: 200
Study: 24421329

Group type: EXPERIMENTAL
Intervention: Pomalidomide + low-dose dexamethasone (POM+LoDEX)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Pomalidomide (POM)
Number of subjects: 221
Study: 22766815

Group type: EXPERIMENTAL
Intervention: Sun cream with jellyfish sting inhibitor
Number of subjects: 38

Group type: COMPARATOR
Intervention: Ordinary sun cream
Number of subjects: 38

Group type: COMPARATOR
Intervention: No cream
Number of subjects: 38
Study: 19541578

Group type: EXPERIMENTAL
Intervention: CNI at 25% of the initial dose + 1000 mg MMF b.i.d. (group 2; n = 13)
Number of subjects: 21

Group type: COMPARATOR
Intervention: CNI-free MMF/prednisone-based treatment (group 1; n = 8)
Number of subjects: 21
Study: 17251060

Group type: EXPERIMENTAL
Intervention: Leukocyte-reduced red cell concentrates (LR-RC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-leukocyte-reduced red cell concentrates (non-LR-RC)
Number of subjects: 100
Study: 15923284

Group type: EXPERIMENTAL
Intervention: Female condoms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diaphragm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microbicide products
Number of subjects: 0
Study: 12224369

Group type: EXPERIMENTAL
Intervention: Calcium acetate gelcaps
Number of subjects: 22

Group type: COMPARATOR
Intervention: Calcium acetate tablets
Number of subjects: 22
Study: 9685102

Group type: EXPERIMENTAL
Intervention: Circuit weight training (CWT) protocols at 40% and 60% of one-repetition maximum (1-RM) with 30 or 60 seconds of rest between exercises.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CWT protocols (60% of 1-RM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Maximal treadmill test
Number of subjects: 0
Study: 8117174

Group type: EXPERIMENTAL
Intervention: Smoking cessation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weight reduction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Myocardial infarction during follow-up
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline left ventricular dysfunction
Number of subjects: 0
Study: 2809914

Group type: EXPERIMENTAL
Intervention: 10% intralipid
Number of subjects: 28

Group type: COMPARATOR
Intervention: 20% intralipid
Number of subjects: 28
Study: 31419490

Group type: EXPERIMENTAL
Intervention: Drug provocation testing (DPT) to amoxicillin over 3 days
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Penicillin allergy evaluation with DPT
Number of subjects: 71
Study: 27660995

Group type: EXPERIMENTAL
Intervention: Intensive psychotherapy (IP; n = 163)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Collaborative care (CC; n = 130)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Intensive psychotherapy (IP)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Collaborative care (CC)
Number of subjects: 243
Study: 25516195

Group type: EXPERIMENTAL
Intervention: High-dose simvastatin (80 mg daily for 3 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-dose simvastatin (40 mg daily for 3 weeks)
Number of subjects: 0
Study: 23321148

Group type: EXPERIMENTAL
Intervention: Covered implants (n=51)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Uncovered implants (n=54)
Number of subjects: 105
Study: 21346609

Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 18977549

Group type: EXPERIMENTAL
Intervention: Fermented milk prepared with Lactobacillus GG (LGG) and L. gasseri TMC0356
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo yoghurt
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fermented milk prepared with Lactobacillus GG (LGG)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fermented milk prepared with L. gasseri TMC0356
Number of subjects: 40
Study: 17501728

Group type: EXPERIMENTAL
Intervention: PECS training for teachers (2-day workshop + 6 half-day sessions over 5 months)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (delayed treatment, no treatment)
Number of subjects: 84
Study: 15675430

Group type: EXPERIMENTAL
Intervention: Laying the patient on the paretic side
Number of subjects: 10

Group type: COMPARATOR
Intervention: Laying the patient on the non-paretic side
Number of subjects: 10
Study: 12208675

Group type: EXPERIMENTAL
Intervention: Mist (humidified oxygen)
Number of subjects: 71

Group type: COMPARATOR
Intervention: No mist
Number of subjects: 71
Study: 9658726

Group type: EXPERIMENTAL
Intervention: R-1 (CBDCA 300 mg/m2/d on days 1-4, HIDAC 1 g/m2/bd on days 1-5, mitoxantrone/idarubicin 12/6 mg/m2/d on days 1-3)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: R-2 (CBDCA and G-CSF as above, HIDAC on alternate days, mitoxantrone/idarubicin 8/5 mg/m2/dose)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Responders (complete and partial)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 29
Study: 7980831

Group type: EXPERIMENTAL
Intervention: Response options for frequency of alcohol use items in a self‐administered microcomputer interview
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Order of presentation of close‐ended response options
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Relative placement of alcohol use items in the questionnaire
Number of subjects: 296
Study: 2588564

Group type: EXPERIMENTAL
Intervention: Active specific intralymphatic immunotherapy (autologous, cryopreserved, irradiated tumor cells)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low-dose cyclophosphamide (300 mg per m2) administered 3 days before the autologous cell vaccine
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tumor cells treated with cholesteryl hemisuccinate before irradiation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Active specific intralymphatic immunotherapy
Number of subjects: 32
Study: 1138671

Group type: EXPERIMENTAL
Intervention: Intake of 2,200 mg of phosphorus and 2,400 mg of calcium
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Addition of vitamin D
Number of subjects: 29
Study: 31858835

Group type: EXPERIMENTAL
Intervention: Inhibition Training (IT) group, received training based on a hybrid flanker Go/No-go task, 4 consecutive daily training sessions of 20 minutes each.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noninhibition-based (episodic memory; EM) training group.
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-Training (NT) group, control for test-retest effects.
Number of subjects: 0
Study: 30130323

Group type: EXPERIMENTAL
Intervention: Intra‐BM allogeneic islet transplantation (n = 3)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Islets in the liver (n = 6)
Number of subjects: 13
Study: 28041830

Group type: EXPERIMENTAL
Intervention: Luteal phase HCG support (single mid-luteal HCG injection)
Number of subjects: 98

Group type: COMPARATOR
Intervention: No HCG support
Number of subjects: 98
Study: 25934458

Group type: EXPERIMENTAL
Intervention: 3‐times‐per-week, 60‐minute structured exercise program for 8 weeks (24 sessions)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Health education control group
Number of subjects: 135
Study: 24283136

Group type: EXPERIMENTAL
Intervention: Spray vaccination with Poulvac E. coli (aroA-deficient mutant strain)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simultaneous use of vaccine with antibiotic ceftiofur sodium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spray vaccination
Number of subjects: 0
Study: 21150784

Group type: EXPERIMENTAL
Intervention: Idursulfase (0.5 mg/kg weekly for 2 years)
Number of subjects: 94
Study: 18645347

Group type: EXPERIMENTAL
Intervention: Nutritional intervention and combination therapy with metformin and glimepiride
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Triple oral therapy (glimepiride + metformin + rosiglitazone)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Insulin therapy
Number of subjects: 189

Group type: COMPARATOR
Intervention: Non-insulin-requiring group
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Insulin-requiring group
Number of subjects: 189

Group type: COMPARATOR
Intervention: Non-insulin-requiring patients
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Insulin-requiring patients
Number of subjects: 189
Study: 17767120

Group type: EXPERIMENTAL
Intervention: Peppermint gel
Number of subjects: 216

Group type: COMPARATOR
Intervention: Lanolin ointment
Number of subjects: 216

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 216
Study: 15586331

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite (HA) coating
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Screws (S)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Pegs (P)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Press-fit technique only (PF)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Ethylene oxide-sterilized polyethylene liner
Number of subjects: 81
Study: 11548842

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (4 cycles of docetaxel 75 mg/m2 and doxorubicin 50 mg/m2)
Number of subjects: 101
Study: 9257210

Group type: EXPERIMENTAL
Intervention: Intrathecal opioid (10 micrograms/kg morphine and 25 micrograms fentanyl)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (no intrathecal opioid, received 25 to 50 micrograms/kg fentanyl and 0.05 to 0.1 mg/kg midazolam intraoperatively)
Number of subjects: 21
Study: 8279691

Group type: EXPERIMENTAL
Intervention: Hammock position (30 degrees trunk elevation with 30 degrees leg elevation)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Horizontal position (supine)
Number of subjects: 30
Study: 3495151

Group type: EXPERIMENTAL
Intervention: RF power level 0.2 W/kg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: RF power level 0.8 W/kg
Number of subjects: 27

Group type: COMPARATOR
Intervention: RF power level 0 W/kg
Number of subjects: 27

Group type: COMPARATOR
Intervention: RF power level 0.2 W/kg (head scans)
Number of subjects: 27

Group type: COMPARATOR
Intervention: RF power level 0.8 W/kg (head scans)
Number of subjects: 27